Loading...

APC/Cyanine7 anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_APCCyanine7_F4-80_Antibody_020119
Thioglycolate-elicited Balb/c mouse peritoneal macrophages were stained with CD11b FITC and F4/80 (clone BM8) APC/Cyanine7 (left) or Rat IgG2a, ? APC/Cyanine7 isotype control (right).
  • BM8_APCCyanine7_F4-80_Antibody_020119
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages were stained with CD11b FITC and F4/80 (clone BM8) APC/Cyanine7 (left) or Rat IgG2a, ? APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
123117 25 µg 111€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123118 100 µg 260€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 1.0 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  2. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  3. Bruand M, et al. 2021. Cell Reports. 36(3):109412. PubMed
  4. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  5. Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed
  6. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  7. Resende M, et al. 2017. J Immunol. 10.4049/jimmunol.1601701. PubMed
  8. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  9. Pilch Z, et al. 2018. Cancer Immunol Res. 6:930. PubMed
  10. Diao L, et al. 2022. iScience. 25:105511. PubMed
  11. Nawaz A, et al. 2022. Nat Commun. 13:7058. PubMed
  12. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  13. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  14. Vicario N, et al. 2021. Cell Death Disease. 12(7):625. PubMed
  15. Culina S, et al. 2014. PLoS One. 9:88365. PubMed
  16. Kozijn AE, et al. 2019. Osteoarthritis Cartilage. 27:118. PubMed
  17. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  18. Nguyen SL, et al. 2021. Sci Rep. 11:4217. PubMed
  19. Li S, et al. 2021. Ann Transl Med. 9:1644. PubMed
  20. Dias AMM, et al. 2021. J Gastroenterol. 56:442. PubMed
  21. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  22. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  23. Ushio A, et al. 2017. Int J Mol Sci. 10.3390/ijms18061209. PubMed
  24. Wang X, et al. 2020. Signal Transduct Target Ther. 5:35. PubMed
  25. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  26. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  27. Han YH, et al. 2021. Science. 373:. PubMed
  28. Forni MF, et al. 2021. Front Oncol. 11:667715. PubMed
  29. Chen C, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.02.040. PubMed
  30. Herbst S, et al. 2013. Dis Model Mech. 6:643. PubMed
  31. Ohta S, et al. 2013. J Immunol. 190:5927. PubMed
  32. Mason K, et al. 2013. J Immunol. 191:2457. PubMed
  33. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  34. Li J, et al. 2020. Cancer Discov. . PubMed
  35. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  36. Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed
  37. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  38. Peruzzotti-Jametti L, et al. 2021. PLoS Biol. 19:e3001166. PubMed
  39. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  40. Taguchi K, et al. 2015. J Urol. . PubMed
  41. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  42. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  43. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  44. Gao S, et al. 2022. Cell Res. 32:38. PubMed
  45. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  46. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  47. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  48. Li J, et al. 2018. Immunity. 49:178. PubMed
  49. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  50. Yang M, et al. 2021. Cancer Immunol Immunother. 70:2467. PubMed
  51. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  52. Xue N, et al. 2017. Sci Rep. 7:39011. PubMed
  53. Watanabe E, et al. 2020. Angiogenesis. 23(4):667-684. PubMed
  54. Haloul M, et al. 2019. Sci Rep. 9:14050. PubMed
  55. Guo M, et al. 2018. J Immunol. 200:1039. PubMed
  56. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  57. Bugler-Lamb AR, et al. 2021. Mol Metab. 49:101197. PubMed
  58. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  59. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  60. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  61. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  62. De Simone G, et al. 2021. Immunity. :. PubMed
  63. Pilch Z, et al. 2019. PLoS One. 14:e0210796. PubMed
  64. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  65. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  66. Blriot C, et al. 2021. Immunity. :. PubMed
  67. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  68. Zordan P, et al. 2013. Eur J Pharmacol. 715:296. PubMed
  69. Kolodkin-Gal D, et al. 2021. Gut. Online ahead of print. PubMed
  70. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  71. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  72. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  73. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  74. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  75. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  76. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  77. Dichtl S, et al. 2022. Life Sci Alliance. 5:. PubMed
  78. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  79. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  80. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  81. de Assis LVM, et al. 2022. Commun Biol. 5:461. PubMed
  82. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  83. Ni Y, et al. 2021. Theranostics. 11:9431. PubMed
  84. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  85. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  86. Natale CA, et al. 2018. Elife. 7. PubMed
  87. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  88. Zhang Z, et al. 2020. Front Immunol. 11:583276. PubMed
  89. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  90. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  91. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  92. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  93. Peruzzotti-Jametti L, et al. 2018. Cell Stem Cell. 22:355. PubMed
  94. Leiria LO et al. 2019. Cell Metab. 30(4):768-783 . PubMed
  95. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  96. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  97. Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
  98. DeFalco T, et al. 2016. Cell Rep. 12: 1107-1119. PubMed
  99. Bertuzzi M, et al. 2014. PLoS Pathog. 10:1004413. PubMed
  100. Celià-Terrassa T, et al. 2017. Nat Cell Biol. 19:711. PubMed
  101. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  102. Herbst S, et al. 2015. EMBO Mol Med. 30:240. PubMed
  103. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  104. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  105. Kahn JH, et al. 2020. Endocrinology. 161(10):. PubMed
  106. Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed
  107. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  108. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  109. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  110. Sameshima A, et al. 2015. J Endocrinol. 227: 25-36. PubMed
  111. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  112. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
RRID
AB_893489 (BioLegend Cat. No. 123117)
AB_893477 (BioLegend Cat. No. 123118)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kuffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 02-01-2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Brilliant Violet 605™ anti-mouse F4/80

  • Purified anti-mouse F4/80

  • Biotin anti-mouse F4/80

  • FITC anti-mouse F4/80

  • PE anti-mouse F4/80

  • PE/Cyanine5 anti-mouse F4/80

  • PE/Cyanine7 anti-mouse F4/80

  • APC anti-mouse F4/80

  • APC/Cyanine7 anti-mouse F4/80

  • Alexa Fluor® 488 anti-mouse F4/80

  • Alexa Fluor® 647 anti-mouse F4/80

  • Pacific Blue™ anti-mouse F4/80

  • PerCP anti-mouse F4/80

  • PerCP/Cyanine5.5 anti-mouse F4/80

  • Alexa Fluor® 700 anti-mouse F4/80

  • Brilliant Violet 421™ anti-mouse F4/80

  • Brilliant Violet 510™ anti-mouse F4/80

  • Alexa Fluor® 594 anti-mouse F4/80

  • Brilliant Violet 785™ anti-mouse F4/80

  • Purified anti-mouse F4/80 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse F4/80

  • Brilliant Violet 650™ anti-mouse F4/80

  • Brilliant Violet 711™ anti-mouse F4/80

  • APC/Fire™ 750 anti-mouse F4/80

  • TotalSeq™-A0114 anti-mouse F4/80

  • TotalSeq™-B0114 anti-mouse F4/80

  • TotalSeq™-C0114 anti-mouse F4/80

  • Spark YG™ 570 anti-mouse F4/80

  • KIRAVIA Blue 520™ anti-mouse F4/80

  • Ultra-LEAF™ Purified anti-mouse F4/80

  • APC/Fire™ 810 anti-mouse F4/80

  • Spark NIR™ 685 anti-mouse F4/80

  • Spark Blue™ 550 anti-mouse F4/80
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account